Companies › Biogen

Biogen

Company Pharma & Medical Devices

Biogen is listed as a company in Pharma & Medical Devices. It has filed 4 comment letters on 4 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
4
Rules commented on
4
First letter
2025-09-16
Latest letter
2026-09-02
Agencies most often
Centers for Medicare & Medicaid Services (4)

Activity by year

20251
20263

Letters

2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-02
Read the letter ↗

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

CMS-2025-1889Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25 · filed as “Biogen, Inc.”
Read the letter ↗

Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

CMS-2025-1888Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25 · filed as “Biogen, Inc.”
Read the letter ↗

2025

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction

CMS-2025-0304Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-09-16 · filed as “Biogen, Inc.”
Read the letter ↗